Detection of circulating tumor DNA following neoadjuvant chemotherapy and surgery to anticipate early relapse in ER positive and HER2 negative breast cancer: Analysis from the PENELOPE-B trial
Literature
Read More
Multimodal detection in plasma of molecular residual disease (MRD) in locally advanced head and neck squamous cell carcinoma (LA-HNSCC)
Literature
Read More
Validation of recurrence prediction using circulating tumor DNA in patients with curatively treated early stage non-small cell lung cancer
Literature
Read More
NeoGenomics to Participate at the Goldman Sachs 44th Annual Global Healthcare Conference
Press Release
Read More
NeoGenomics to Showcase the Transformational Impact of RaDaR(R) Assay for Molecular Residual Disease and Recurrence Monitoring at ASCO
Press Release
Read More
NeoGenomics to Participate at the BofA Securities 2023 Healthcare Conference
Press Release
Read More
Spatial Analysis of Genomic Signatures on Colorectal Cancer Pathogenesis Using the NanoString GeoMx® Digital Spatial Profiler
Literature
Read More